{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-152345","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.902985+00:00","generated_at":"2026-05-18T12:50:34.264436+00:00","sec_items":["1.01","2.03","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Jaguar Health cuts royalty debt by $6.5M, issues Series M preferred to Iliad and Streeterville","bullets":["Issued 170 shares of Series M Preferred to Iliad for $4.25M reduction in October 2020 royalty interest.","Issued 90 shares of Series M Preferred to Streeterville for $2.25M reduction in August 2022 royalty interest.","Series M Preferred has $25,000 stated value, no dividends, and accrues a preferred return (10%-6% declining).","Company may exchange Series M shares for common stock at the lower of closing or 5-day average price.","Preferred holders gain consent rights over equity issuances, asset sales, and reverse splits."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-152345","json":"https://secwatch.observer/filing/0001193125-25-152345.json","markdown":"https://secwatch.observer/filing/0001193125-25-152345.md","text":"https://secwatch.observer/filing/0001193125-25-152345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525152345/0001193125-25-152345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525152345/d14926d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:50:34.264436+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"edf44c61e8267baf71ca9461fbbf636878b10a5d","claim":"Jaguar Health, Inc.: Filed Series M Certificate of Designation for preferred stock, establishing terms, rights, and preferences (effective 2025-06-27).","evidence_excerpt":"The preferences, rights, limitations and other matters relating to the Series M Preferred Stock are set forth in the Certificate of Designation, which the Company filed with the Secretary of State of the State of Delaware on June 27, 2025.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525152345/0001193125-25-152345-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-27"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}